(PRGS) Progress Software - Ratings and Ratios
AI, DevOps, Data Connectivity, App Development, Network Security
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 33.9% |
| Value at Risk 5%th | 46.9% |
| Relative Tail Risk | -15.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.25 |
| Alpha | -48.31 |
| CAGR/Max DD | -0.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.585 |
| Beta | 0.715 |
| Beta Downside | 0.438 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.60% |
| Mean DD | 12.95% |
| Median DD | 10.10% |
Description: PRGS Progress Software November 11, 2025
Progress Software (NASDAQ:PRGS) builds and manages AI-enhanced software solutions ranging from DevOps automation (Chef) and decision-automation (Corticon) to data-connectivity (DataDirect), low-code development (OpenEdge), and network monitoring (WhatsUp Gold). Its portfolio also includes cloud-native load balancing (Kemp LoadMaster), secure file transfer (MOVEit), and AI-driven digital experience tools (Sitefinity, ShareFile). The company sells directly and through a channel ecosystem of ISVs, OEMs, system integrators, VARs and distributors, serving enterprise customers worldwide.
In FY 2023 Progress reported revenue of approximately $1.2 billion, up roughly 9 % year-over-year, with an operating margin near 15 %. The subscription-based SaaS component now represents over 45 % of total revenue, reflecting a broader industry shift toward recurring-revenue models.
Key macro drivers include accelerating enterprise cloud migration, which fuels demand for DevSecOps tools and secure data-integration platforms, and the expanding AI software market-projected to exceed $1.5 trillion by 2028-providing tailwinds for Progress’s AI-powered offerings.
For a deeper quantitative assessment of PRGS’s valuation relative to peers, the ValueRay platform offers a concise dashboard of forward-looking multiples and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (48.5m TTM) > 0 and > 6% of Revenue (6% = 56.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -5.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -46.19% (prev 10.29%; Δ -56.49pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 192.0m > Net Income 48.5m (YES >=105%, WARN >=100%) |
| Net Debt (731.8m) to EBITDA (280.1m) ratio: 2.61 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (43.7m) change vs 12m ago 0.01% (target <= -2.0% for YES) |
| Gross Margin 81.11% (prev 77.45%; Δ 3.66pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.52% (prev 44.16%; Δ 2.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.10 (EBITDA TTM 280.1m / Interest Expense TTM 65.2m) >= 6 (WARN >= 3) |
Altman Z'' -0.48
| (A) -0.18 = (Total Current Assets 335.5m - Total Current Liabilities 769.8m) / Total Assets 2.42b |
| (B) 0.06 = Retained Earnings (Balance) 138.1m / Total Assets 2.42b |
| (C) 0.07 = EBIT TTM 136.8m / Avg Total Assets 2.02b |
| (D) 0.05 = Book Value of Equity 106.1m / Total Liabilities 1.94b |
| Total Rating: -0.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.06
| 1. Piotroski 4.50pt |
| 2. FCF Yield 7.16% |
| 3. FCF Margin 19.82% |
| 4. Debt/Equity 1.74 |
| 5. Debt/Ebitda 2.61 |
| 6. ROIC - WACC (= -1.21)% |
| 7. RoE 10.78% |
| 8. Rev. Trend 95.33% |
| 9. EPS Trend -10.05% |
What is the price of PRGS shares?
Over the past week, the price has changed by +4.64%, over one month by +2.85%, over three months by -1.92% and over the past year by -37.90%.
Is PRGS a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PRGS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.3 | 57.7% |
| Analysts Target Price | 68.3 | 57.7% |
| ValueRay Target Price | 39.6 | -8.6% |
PRGS Fundamental Data Overview December 05, 2025
P/E Trailing = 39.0811
P/E Forward = 7.1327
P/S = 1.9891
P/B = 3.7681
P/EG = 1.4269
Beta = 0.633
Revenue TTM = 940.1m USD
EBIT TTM = 136.8m USD
EBITDA TTM = 280.1m USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 8.79m USD (from shortTermDebt, last quarter)
Debt = 830.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 731.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.60b USD (1.87b + Debt 830.8m - CCE 99.0m)
Interest Coverage Ratio = 2.10 (Ebit TTM 136.8m / Interest Expense TTM 65.2m)
FCF Yield = 7.16% (FCF TTM 186.3m / Enterprise Value 2.60b)
FCF Margin = 19.82% (FCF TTM 186.3m / Revenue TTM 940.1m)
Net Margin = 5.16% (Net Income TTM 48.5m / Revenue TTM 940.1m)
Gross Margin = 81.11% ((Revenue TTM 940.1m - Cost of Revenue TTM 177.6m) / Revenue TTM)
Gross Margin QoQ = 80.97% (prev 80.08%)
Tobins Q-Ratio = 1.07 (Enterprise Value 2.60b / Total Assets 2.42b)
Interest Expense / Debt = 2.13% (Interest Expense 17.7m / Debt 830.8m)
Taxrate = 25.92% (6.79m / 26.2m)
NOPAT = 101.4m (EBIT 136.8m * (1 - 25.92%))
Current Ratio = 0.44 (Total Current Assets 335.5m / Total Current Liabilities 769.8m)
Debt / Equity = 1.74 (Debt 830.8m / totalStockholderEquity, last quarter 477.7m)
Debt / EBITDA = 2.61 (Net Debt 731.8m / EBITDA 280.1m)
Debt / FCF = 3.93 (Net Debt 731.8m / FCF TTM 186.3m)
Total Stockholder Equity = 450.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.00% (Net Income 48.5m / Total Assets 2.42b)
RoE = 10.78% (Net Income TTM 48.5m / Total Stockholder Equity 450.3m)
RoCE = 9.06% (EBIT 136.8m / Capital Employed (Equity 450.3m + L.T.Debt 1.06b))
RoIC = 5.26% (NOPAT 101.4m / Invested Capital 1.93b)
WACC = 6.48% (E(1.87b)/V(2.70b) * Re(8.65%) + D(830.8m)/V(2.70b) * Rd(2.13%) * (1-Tc(0.26)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.25%
[DCF Debug] Terminal Value 76.68% ; FCFE base≈199.9m ; Y1≈207.4m ; Y5≈236.8m
Fair Price DCF = 86.65 (DCF Value 3.72b / Shares Outstanding 42.9m; 5y FCF grow 3.89% → 3.0% )
EPS Correlation: -10.05 | EPS CAGR: -45.56% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.33 | Revenue CAGR: 16.67% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-02-28): EPS=1.41 | Chg30d=+0.018 | Revisions Net=+3 | Analysts=6
EPS next Year (2026-11-30): EPS=5.68 | Chg30d=+0.064 | Revisions Net=+0 | Growth EPS=+2.7% | Growth Revenue=+1.5%
Additional Sources for PRGS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle